Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000368147 | SCV000330206 | pathogenic | not provided | 2016-01-21 | criteria provided, single submitter | clinical testing | The c.615dupC pathogenic variant in the MCOLN1 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The c.615dupC variant causes a frameshift starting with codon Serine 206, changes this amino acid to a Glutamine residue, and creates a premature Stop codon at position 36 of the new reading frame, denoted p.Ser206GlnfsX36. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The c.615dupC variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. We interpret c.615dupC as a pathogenic variant. |
Invitae | RCV001855065 | SCV002225883 | pathogenic | Mucolipidosis type IV | 2022-01-18 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with MCOLN1-related conditions. For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 280304). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Ser206Glnfs*36) in the MCOLN1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MCOLN1 are known to be pathogenic (PMID: 11030752, 11317355). |